AVADEL PHARMACEUTICALS PLC - Ordinary Shares, nominal value $0.01 per share (AVDL)

CUSIP: G29687103

Q3 2024 13F Holders as of 30 Sep 2024

Type / Class
Equity / Ordinary Shares, nominal value $0.01 per share
Shares outstanding
95,992,895
Total 13F shares
73,371,084
Share change
+6,632,678
Total reported value
$962,302,695
Put/Call ratio
142%
Price per share
$13.12
Number of holders
169
Value change
+$83,134,728
Number of buys
101
Number of sells
62

Quarterly Holders Quick Answers

What is CUSIP G29687103?
CUSIP G29687103 identifies AVDL - AVADEL PHARMACEUTICALS PLC - Ordinary Shares, nominal value $0.01 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of AVADEL PHARMACEUTICALS PLC - Ordinary Shares, nominal value $0.01 per share (AVDL) as of Q3 2024

As of 30 Sep 2024, AVADEL PHARMACEUTICALS PLC - Ordinary Shares, nominal value $0.01 per share (AVDL) was held by 169 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 73,371,084 shares. The largest 10 holders included JANUS HENDERSON GROUP PLC, GENDELL JEFFREY L, BlackRock, Inc., Polar Capital Holdings Plc, VANGUARD GROUP INC, BRAIDWELL LP, Vivo Capital, LLC, CITADEL ADVISORS LLC, Two Seas Capital LP, and WEALTH EFFECTS LLC. This page lists 169 institutional shareholders reporting positions in this security for the Q3 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.